NDC 50090-0375 Cyclobenzaprine Hydrochloride

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
50090-0375
Proprietary Name:
Cyclobenzaprine Hydrochloride
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
A-s Medication Solutions
Labeler Code:
50090
Start Marketing Date: [9]
02-28-2007
Listing Expiration Date: [11]
12-31-2018
Exclude Flag: [12]
I
Code Navigator:

Product Characteristics

Color(s):
YELLOW (C48330)
Shape:
ROUND (C48348)
Size(s):
7 MM
Imprint(s):
2632;V
Score:
1

Product Packages

NDC Code 50090-0375-0

Package Description: 15 TABLET, FILM COATED in 1 BOTTLE

NDC Code 50090-0375-1

Package Description: 20 TABLET, FILM COATED in 1 BOTTLE

NDC Code 50090-0375-2

Package Description: 30 TABLET, FILM COATED in 1 BOTTLE

NDC Code 50090-0375-3

Package Description: 60 TABLET, FILM COATED in 1 BOTTLE

NDC Code 50090-0375-4

Package Description: 100 TABLET, FILM COATED in 1 BOTTLE

NDC Code 50090-0375-6

Package Description: 7 TABLET, FILM COATED in 1 BOTTLE

NDC Code 50090-0375-7

Package Description: 14 TABLET, FILM COATED in 1 BOTTLE

NDC Code 50090-0375-8

Package Description: 21 TABLET, FILM COATED in 1 BOTTLE

NDC Code 50090-0375-9

Package Description: 10 TABLET, FILM COATED in 1 BOTTLE

Product Details

What is NDC 50090-0375?

The NDC code 50090-0375 is assigned by the FDA to the product Cyclobenzaprine Hydrochloride which is product labeled by A-s Medication Solutions. The product's dosage form is . The product is distributed in 9 packages with assigned NDC codes 50090-0375-0 15 tablet, film coated in 1 bottle , 50090-0375-1 20 tablet, film coated in 1 bottle , 50090-0375-2 30 tablet, film coated in 1 bottle , 50090-0375-3 60 tablet, film coated in 1 bottle , 50090-0375-4 100 tablet, film coated in 1 bottle , 50090-0375-6 7 tablet, film coated in 1 bottle , 50090-0375-7 14 tablet, film coated in 1 bottle , 50090-0375-8 21 tablet, film coated in 1 bottle , 50090-0375-9 10 tablet, film coated in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Cyclobenzaprine Hydrochloride?

Cyclobenzaprine hydrochloride tablets are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living.Cyclobenzaprine hydrochloride tablets should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted.Cyclobenzaprine hydrochloride tablets have not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy.

Which are Cyclobenzaprine Hydrochloride UNII Codes?

The UNII codes for the active ingredients in this product are:

  • CYCLOBENZAPRINE HYDROCHLORIDE (UNII: 0VE05JYS2P)
  • CYCLOBENZAPRINE (UNII: 69O5WQQ5TI) (Active Moiety)

Which are Cyclobenzaprine Hydrochloride Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Cyclobenzaprine Hydrochloride?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".